Engineering Tools for the Development of Recombinant Lactic Acid Bacteria

被引:30
作者
Cho, Sung Won [1 ]
Yim, Jaewoo [1 ]
Seo, Sang Woo [1 ]
机构
[1] Seoul Natl Univ, Inst Chem Proc, Sch Chem & Biol Engn, 1 Gwanak Ro, Seoul 08826, South Korea
基金
新加坡国家研究基金会;
关键词
genetic engineering; lactic acid bacteria; synthetic biology; CONTROLLED GENE-EXPRESSION; LACTOCOCCUS-LACTIS; LACTOBACILLUS-PLANTARUM; CLONING VECTORS; TECHNICAL CONDITIONS; REPLICATION REGION; BACILLUS-SUBTILIS; ORAL IMMUNIZATION; MUCOSAL DELIVERY; SIGNAL PEPTIDES;
D O I
10.1002/biot.201900344
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Lactic acid bacteria (LAB) is mainly used in food fermentation. In addition, LAB fermentation technology has been studied in the development of industrial food additives, nutrients, or enzymes used in food processing. In the field of red biotechnology, LAB is approved and is generally recognized as a safe organism and is considered safe for biotherapeutic treatments. Recent clinical trials have demonstrated the medicinal value of therapeutic recombinant LAB and the suitability of innate mechanisms of secretion and anchoring for therapeutic applications such as antibody or vaccine production. However, the gram-positive phenotypic trait of LAB creates challenges for genetic modifications when compared to other conventional workhorse bacteria, resulting in exclusive developments of genetic tools for engineering LAB. In this review, several distinct approaches in gene expression for engineering LAB are discussed.
引用
收藏
页数:10
相关论文
共 121 条
  • [1] Transformation of Lactobacillus plantarum by electroporation with in vitro modified plasmid DNA
    Alegre, MT
    Rodríguez, MC
    Mesas, JM
    [J]. FEMS MICROBIOLOGY LETTERS, 2004, 241 (01) : 73 - 77
  • [2] Functional analysis of the gene encoding immunity to lactacin F, lafI, and its use as a Lactobacillus-specific, food-grade genetic marker
    Allison, GE
    Klaenhammer, TR
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1996, 62 (12) : 4450 - 4460
  • [3] In situ gastrointestinal protection against anthrax edema toxin by single-chain antibody fragment producing lactobacilli
    Andersen, Kasper Krogh
    Marcotte, Harold
    Alvarez, Beatriz
    Boyaka, Prosper N.
    Hammarstrom, Lennart
    [J]. BMC BIOTECHNOLOGY, 2011, 11
  • [4] Characterization of Erythromycin and Tetracycline Resistance in Lactobacillus fermentum Strains
    Anisimova, Elizaveta
    Yarullina, Dina
    [J]. INTERNATIONAL JOURNAL OF MICROBIOLOGY, 2018, 2018
  • [5] A convenient and reproducible method to genetically transform bacteria of the genus Bifidobacterium
    Argnani, A
    Leer, RJ
    vanLuijk, N
    Pouwels, PH
    [J]. MICROBIOLOGY-UK, 1996, 142 : 109 - 114
  • [6] Aukrust T W, 1995, Methods Mol Biol, V47, P201
  • [7] SPHEROPLAST AND ELECTROPORATION-MEDIATED TRANSFORMATION OF LACTOBACILLUS-PLANTARUM
    BADII, R
    JONES, S
    WARNER, PJ
    [J]. LETTERS IN APPLIED MICROBIOLOGY, 1989, 9 (02) : 41 - 44
  • [8] Lactococcus lactis as a Cell Factory for Delivery of Therapeutic Proteins
    Bahey-El-Din, Mohammed
    Gahan, Cormac G. M.
    Griffin, Brendan T.
    [J]. CURRENT GENE THERAPY, 2010, 10 (01) : 34 - 45
  • [9] Development of a Stress-Inducible Controlled Expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces
    Benbouziane, Bouasria
    Ribelles, Pedro
    Aubry, Camille
    Martin, Rebeca
    Kharrat, Pascale
    Riazi, Ali
    Langella, Philippe
    Bermudez-Humaran, Luis G.
    [J]. JOURNAL OF BIOTECHNOLOGY, 2013, 168 (02) : 120 - 129
  • [10] Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci
    Bermudez-Humaran, Luis G.
    Motta, Jean-Paul
    Aubry, Camille
    Kharrat, Pascale
    Rous-Martin, Laurence
    Sallenave, Jean-Michel
    Deraison, Celine
    Vergnolle, Nathalie
    Langella, Philippe
    [J]. MICROBIAL CELL FACTORIES, 2015, 14